Minkyu Jung
Yonsei Cencer center · Yonsei Cancer Center, Yonsei University College of Medicine · Division of Medical Oncology, Department of Internal Medicine, Yonsei cancer center, Severance Hospital, Yonsei University Healthy System
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Minkyu Jung as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:48 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06767436 · A Multi-center Real-world Efficacy and Safety of Trastuzumab-deruxtecan in Advanced Gastric CancerYonsei University · recruiting · Advanced Gastric Cancer · principal investigator
- Ph2NCT05882292 · c-MET Inhibitor in Advanced Solid Tumors With c-MET Gene AberrationYonsei University · recruiting · Neoplasms · principal investigator
- N/ANCT05573776 · A Pilot Study of the Effect of High Protein Supplement and Exercise Therapy on Preservation of Skeletal Muscle Mass and Quality of Life in Patients With Gastric Cancer and Pancreatic Cancer Treated With ChemotherapyYonsei University · completed · Gastric Cancer, Pancreatic Cancer · principal investigator
- Ph2NCT05436990 · Antitumor Activity of Vactosertib in Combination With Pembrolizumab in Acral and Mucosal Melanoma Patients Progressed From Prior Immune Check Point InhibitorYonsei University · terminated · Acral Melanoma, Mucosal Melanoma · principal investigator
- Ph1NCT04262739 · MTD, Safety and Efficacy of NYH817G and NYH100P in Monotherapy and Combination in Patients With Advanced Solid TumorsHaim Bio Co., Ltd. · unknown · Advanced Solid Tumors · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:48 UTC. The ranking covers the 200 most relevant of 238 PubMed records, and a shared surname and initials can bring in a namesake. All 238 on PubMed
- Development of a second-generation antiandrogen for treatment of advanced prostate cancer.Science · 20091,832 citationsRCR 40.9
- Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance.Gastroenterology · 2003405 citationsRCR 9.6
- In vivo histology of Barrett's esophagus and associated neoplasia by confocal laser endomicroscopy.Clin Gastroenterol Hepatol · 2006356 citationsRCR 10.3
- 322 citationsRCR 19.6
- 238 citationsRCR 11.9
- Effects of high-intensity interval exercise versus continuous moderate-intensity exercise on postprandial glycemic control assessed by continuous glucose monitoring in obese adults.Appl Physiol Nutr Metab · 2014150 citationsRCR 6.3
- Improved sedation in diagnostic and therapeutic ERCP: propofol is an alternative to midazolam.Endoscopy · 2000148 citationsRCR 6.8
- High-intensity interval training as an efficacious alternative to moderate-intensity continuous training for adults with prediabetes.J Diabetes Res · 2015126 citationsRCR 5.8
- A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatment.J Exp Med · 2021121 citationsRCR 7.6
- A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer.Cancer Chemother Pharmacol · 2014112 citationsRCR 4.0